Home

  1. News
  2. Newsletter
By Lynn Kirkpatrick, as published in DTC Perspectives, November 11, 2025 If the FDA’s targeting of TV ads and social media influencers makes one thing clear, it’s that the biopharma industry is under the microscope. Promotions once considered “safe” are now fair game for untitled letters, warning letters and cease-and-desists. Understanding this new environment matters, […]